Contaminate, Legislate, Repeat: How Disasters have Shaped our Pharma Regulatory Landscape

Add bookmark

The pharmaceuticals industry is one of the most tightly regulated industries on the planet, with many in the industry claiming that overregulation is stifling the industry and preventing the discovery of new, potentially life-saving medicines. It is important then to wonder how did we get here. Our editor examines the major cases which shaped the legislative landscape; from Sulfanilamide to the thalidomide tragedy, the major changes to regulation of the pharma industry have come following a high profile disaster. Read about these world-changing cases in Pharma IQ’s Contaminate, Legislate, Repeat.

Do we need to review our current legislation?

Is there a potential disaster waiting for us?

How can we find a balance between public safety and a successful pharmaceutical industry?

Latest Webinars

Pharma IQ's Power List 2022: In conversation with pharma's top leaders

2022-10-18

02:00 PM - 03:00 PM BST

Join us to hear from the most influential people in pharma today, as voted for by you

A post-pandemic 3D view of the patient and supply journey

2022-06-01

04:30 PM - 05:30 PM CET

In this panel discussion with experts from 4G Clinical, THREAD Research and World Courier, learn how...

Discover how targeted radiotherapy induced toxicity can be identified with imaging

2022-04-28

01:00 PM - 02:00 PM EST

This Pharma IQ webinar with AIQ explores how AI-assisted analysis of radiological scans enhances the...

Recommended